A REDCAR biotechnology company has been providing antibody services for scientists working on coronavirus research globally.

Absolute Antibody, based in the Wilton Centre in Lazenby has been developing Covid-19 treatments to send to companies trying to develop a vaccine.

The company provides antibody services and research tools to the pharmaceutical companies and scientists working on defeating coronavirus.

For example, they are manufacturing human antibodies sequenced from patients recovering from Covid-19 to aid in therapeutic development.

However, it is their customers who would release any resulting antibody treatments.

The company is also providing antibodies that detect the Covid-19 virus for use in diagnostic tests.

Absolute Antibody was founded in 2012.

Catherine Bladen, chief operations officer, said: “We have a vision to be accessible to all scientists, we provide antibody services and research across the world.”

Absolute Antibody was founded in Oxford in 2012 with the vision that all antibody users should be able to use recombinant antibodies, which are absolutely defined by their amino acid sequence.

In 2019 the company’s international headquarters were moved to Redcar.

They are also situated in Boston and Amsterdam.

Dr Bladen, who is from Cleveland, joined the company in 2015.

She worked in America for a number of years but now works in the labs in the Wilton site.

“We’re particularly involved with Covid-19 in detecting the virus,” Dr Bladen said.

The antibodies worked with in the labs will be used in testing kits.

Dr Bladen added: “We’ve just won the Queen’s award in International Trade.”

The company was presented the Queen’s Award for Enterprise in International Trade a couple of weeks ago for its rapid overseas sales growth over the last three years.